Stryker Co. (NYSE:SYK) Shares Acquired by Daiwa Securities Group Inc.

Daiwa Securities Group Inc. raised its holdings in Stryker Co. (NYSE:SYK - Free Report) by 12.3% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 49,003 shares of the medical technology company's stock after acquiring an additional 5,368 shares during the period. Daiwa Securities Group Inc.'s holdings in Stryker were worth $17,703,000 at the end of the most recent quarter.

A number of other institutional investors have also bought and sold shares of the business. Centennial Bank AR grew its holdings in shares of Stryker by 106.7% in the second quarter. Centennial Bank AR now owns 93 shares of the medical technology company's stock valued at $32,000 after purchasing an additional 48 shares during the period. Darwin Wealth Management LLC purchased a new stake in shares of Stryker in the 3rd quarter valued at approximately $36,000. Hara Capital LLC acquired a new stake in shares of Stryker during the 3rd quarter worth approximately $42,000. HBW Advisory Services LLC purchased a new stake in shares of Stryker during the 3rd quarter valued at approximately $42,000. Finally, Grove Bank & Trust lifted its holdings in Stryker by 84.8% in the third quarter. Grove Bank & Trust now owns 122 shares of the medical technology company's stock valued at $44,000 after acquiring an additional 56 shares during the last quarter. 77.09% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, CEO Kevin Lobo sold 57,313 shares of the company's stock in a transaction dated Thursday, November 7th. The stock was sold at an average price of $368.70, for a total value of $21,131,303.10. Following the completion of the sale, the chief executive officer now directly owns 100,027 shares of the company's stock, valued at $36,879,954.90. This represents a 36.43 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, VP M Kathryn Fink sold 7,347 shares of Stryker stock in a transaction that occurred on Tuesday, September 17th. The stock was sold at an average price of $366.98, for a total value of $2,696,202.06. Following the transaction, the vice president now directly owns 10,042 shares in the company, valued at approximately $3,685,213.16. This trade represents a 42.25 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 67,381 shares of company stock worth $24,825,275. 5.50% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several equities research analysts have issued reports on SYK shares. Barclays raised their target price on Stryker from $402.00 to $418.00 and gave the stock an "overweight" rating in a research note on Thursday, October 31st. JPMorgan Chase & Co. raised their price objective on Stryker from $375.00 to $420.00 and gave the stock an "overweight" rating in a research report on Wednesday, October 30th. UBS Group boosted their price objective on shares of Stryker from $366.00 to $370.00 and gave the company a "neutral" rating in a report on Wednesday, October 30th. Evercore ISI increased their target price on shares of Stryker from $380.00 to $384.00 and gave the stock an "outperform" rating in a research note on Wednesday, October 30th. Finally, Needham & Company LLC boosted their price target on shares of Stryker from $393.00 to $409.00 and gave the company a "buy" rating in a research note on Wednesday, October 30th. Five analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $393.65.

Stryker Stock Down 0.1 %

NYSE:SYK traded down $0.22 during mid-day trading on Monday, hitting $384.63. The stock had a trading volume of 2,102,817 shares, compared to its average volume of 1,272,761. Stryker Co. has a twelve month low of $285.79 and a twelve month high of $398.20. The stock has a 50-day simple moving average of $366.45 and a two-hundred day simple moving average of $350.00. The company has a current ratio of 1.91, a quick ratio of 1.22 and a debt-to-equity ratio of 0.66. The company has a market capitalization of $146.63 billion, a PE ratio of 41.23, a PEG ratio of 2.90 and a beta of 0.91.

Stryker (NYSE:SYK - Get Free Report) last issued its earnings results on Tuesday, October 29th. The medical technology company reported $2.87 EPS for the quarter, topping analysts' consensus estimates of $2.77 by $0.10. Stryker had a net margin of 16.34% and a return on equity of 23.07%. The firm had revenue of $5.49 billion during the quarter, compared to the consensus estimate of $5.37 billion. During the same quarter in the previous year, the firm posted $2.46 earnings per share. The company's revenue was up 11.9% compared to the same quarter last year. On average, equities research analysts anticipate that Stryker Co. will post 12.06 EPS for the current year.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.